Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Glenn B. Knight is active.

Publication


Featured researches published by Glenn B. Knight.


Journal of Virological Methods | 1999

A competitive reverse transcription-polymerase chain reaction assay for quantitation of GB virus C/hepatitis G virus RNA that circumvents heteroduplex artifact.

Fanghua Liu; Glenn B. Knight; György Ábel; Vincent Agnello

The role of GB virus C (GBV-C)/hepatitis G virus (HGV) in hepatitis has been controversial. To investigate its possible pathogenicity and site(s) of replication, it is important to develop an accurate quantitative assay for both positive and negative strand GBV-C/HGV RNA. In this study, a competitive reverse transcription-polymerase chain reaction (RT-PCR) assay for both positive and negative strand GBV-C/HGV RNA quantitation was developed. In developing the quantitative assay, heteroduplex formation was repeatedly observed. A heterologous competitor RNA with GBV-C/HGV primer-binding sequences was introduced, and heteroduplex artifact was circumvented successfully. Two-hundred thirty-seven serum specimens were screened by RT-PCR for GBV-C/HGV RNA. Two of the 62 patients infected with chronic hepatitis C virus (HCV) were found to be positive for GBV-C/HGV RNA. None of the 50 other patients with no evidence of HCV infection and none of the 125 normal individuals were positive for GBV-C/HGV RNA. The sensitivity of RT-PCR was 3000 gE/ml (30 gE in RT-PCR). Alternate methods for residual DNA removal and its detection in synthetic RNA were introduced. A RT control containing no primer before PCR is necessary to evaluate the trace amounts of template DNA remaining in synthesized RNA. The method will differentiate reliably between positive and negative strand RNAs up to a 10(4)-fold difference in titer. The positive and negative strand GBV-C/HGV RNAs were detected in one patient by RT-PCR and hybridization analysis, and the strand titer was determined by RT-PCR.


Arthritis & Rheumatism | 1999

Hepatitis C virus but not GB virus C/hepatitis G virus has a role in type II cryoglobulinemia.

Fanghua Liu; Glenn B. Knight; Vincent Agnello

OBJECTIVE Hepatitis C virus (HCV) infection is associated with type II cryoglobulinemia. HCV is specifically concentrated in type II cryoglobulins and has been implicated in the cutaneous vasculitis associated with the disease. In contrast to HCV, a role for hepatitis G virus (HGV) in type II cryoglobulinemia has not been defined, although prevalences as high as 43% of HGV infections in type II cryoglobulinemia have also been reported. METHODS We studied 34 patients with type II and 29 patients with type III cryoglobulinemia associated with HCV infection, 6 patients with essential mixed cryoglobulinemia (EMC; all with type II), 50 hospital control patients, and 125 normal individuals. Serum HCV and HGV RNA were detected by reverse transcription-polymerase chain reaction (RT-PCR). In coinfected sera, HCV and HGV were quantitated by competitive RT-PCR assays. One coinfected patient was studied longitudinally for 6 years. RESULTS Two (5.9%) of 34 patients with HCV-infected type II cryoglobulinemia, none of 29 patients with type III cryoglobulinemia, and none of 6 patients with EMC were positive for HGV RNA, for an overall prevalence of 3.0% in mixed cryoglobulinemia. None of the control populations were positive for HGV. No statistical difference was seen between the prevalence in patients with type II cryoglobulinemia and the other populations studied. In coinfected sera, HCV, but not HGV, was concentrated in cryoglobulins, and HCV, but not HGV, correlated with cryoglobulinemia in a longitudinal study. CONCLUSION There is a low prevalence of coinfection with HGV in patients with mixed cryoglobulinemia and HCV infection in the United States. HCV is selectively precipitated by type II cryoglobulins in coinfected sera. HGV infection does not appear to have a role in mixed cryoglobulinemia.


Autoantibodies | 1996

Cryoglobulins Secondary to Hepatitis C Virus Infection

György Ábel; Glenn B. Knight; Vincent Agnello

Publisher Summary This chapter discusses the cryoglobulins secondary to hepatitis C virus (HCV) infection. There are two types of mixed cryoglobulins: type II contains polyclonal immunoglobulin (IgG) and a monoclonal IgM rheumatoid factors (mRF), while in type III both the IgG and IgM RF are polyclonal. The manifestations of the disease range from a benign cutaneous vasculitis to life-threatening severe vasculitis of vital organs. The high frequency of hepatocellular pathology in patients with essential mixed cryoglobulinemia suggested the involvement of hepatotropic viruses in the pathogenesis of the disease.


Proceedings of the National Academy of Sciences of the United States of America | 1999

Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor

Vincent Agnello; György Ábel; Mutasim Elfahal; Glenn B. Knight; Qing-Xiu Zhang


Blood | 1997

Predictors of Long-Term Response to High-Dose Interferon Therapy in Type II Cryoglobulinemia Associated With Hepatitis C Virus Infection

Milvia Casato; Vincent Agnello; Leopoldo P. Pucillo; Glenn B. Knight; Marco Leoni; Savino Del Vecchio; Cristina Mazzilli; Guido Antonelli; Lorenzo Bonomo


Hepatology | 1998

Detection of widespread hepatocyte infection in chronic hepatitis C

Vincent Agnello; György Ábel; Glenn B. Knight; Elizabeth Muchmore


Blood | 2002

Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia

Milvia Casato; Cristina Mecucci; Vincent Agnello; Massimo Fiorilli; Glenn B. Knight; Caterina Matteucci; Lei Gao; Jonathan Kay


Arthritis & Rheumatism | 2010

Detection of WA B Cells in Hepatitis C Virus Infection: A Potential Prognostic Marker for Cryoglobulinemic Vasculitis and B Cell Malignancies

Glenn B. Knight; Lei Gao; Laura Gragnani; Mutasim Elfahal; Francesco Giuseppe De Rosa; Fredric D. Gordon; Vincent Agnello


Journal of Clinical Microbiology | 2000

Use of Whole Blood Specimens for Routine Clinical Quantitation of Hepatitis C Virus RNA Does Not Increase Assay Sensitivity

Linda S. Cook; Angela M. Ross; Glenn B. Knight; Vincent Agnello


Blood | 2001

WA monoclonal rheumatoid factors and non-Hodgkin lymphoma

Glenn B. Knight; Vincent Agnello

Collaboration


Dive into the Glenn B. Knight's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Milvia Casato

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Guido Antonelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Marco Leoni

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge